A 58-year-old female patient with worsening heart failure presents with increased shortness of breath, lower extremity swelling, elevated JVP, and pulmonary congestion. Her serum creatinine is 2.8 mg/dL, and her liver enzymes are elevated. Which nursing intervention should be prioritized to address her current clinical status?

A) Administer the increased dose of furosemide as ordered

B) Encourage the patient to increase oral fluid intake to support renal function

C) Initiate patient education on low-sodium diet to prevent fluid retention

D) Monitor liver function tests closely to evaluate hepatic status

A 58-year-old female patient with worsening heart failure and chronic kidney disease is experiencing increased shortness of breath, elevated jugular venous pressure, and crackles upon lung auscultation. Her laboratory results show a serum creatinine level of 2.8 mg/dL and an eGFR of 28 mL/min/1.73m², with elevated liver enzymes. Which nursing intervention is most appropriate to prioritize at this time?

A) Administer the increased dose of furosemide as prescribed to manage the fluid overload.

B) Educate the patient on dietary sodium restrictions to prevent fluid retention.

C) Monitor the patient's blood glucose levels due to potential alterations from medication changes.

D) Prepare the patient for dialysis to immediately address the declining renal function.

A patient with heart failure and liver dysfunction is being treated with furosemide and has developed signs of hepatic encephalopathy. The healthcare team is considering initiating lactulose therapy. What is the primary nursing consideration when administering lactulose to this patient?

D) Monitor for signs of dehydration due to increased bowel movements.

A) Monitor for signs of hypokalemia and adjust electrolyte replacement as needed.

B) Assess for increased blood pressure as lactulose may cause hypertension.

C) Evaluate for respiratory distress due to potential fluid overload from lactulose.

D) Monitor for signs of dehydration due to increased bowel movements.

A patient with heart failure, renal impairment, and hepatic dysfunction is being treated with furosemide and has recently been started on lactulose to manage hepatic encephalopathy. Which nursing intervention is most appropriate to prioritize in this scenario?

B) Assess the patient's level of consciousness and neurological status regularly.

A) Monitor the patient's blood pressure and adjust antihypertensive medications as needed.

B) Assess the patient's level of consciousness and neurological status regularly.

C) Increase the patient's fluid intake to enhance kidney function.

D) Encourage a high-protein diet to support liver function.

A patient is receiving lactulose therapy for hepatic encephalopathy. Despite improvements in orientation, the patient reports mild abdominal discomfort and fatigue, and her serum creatinine has increased to 3.6 mg/dL. Considering the patient's current condition and recent laboratory findings, what is the most appropriate nursing action to prioritize?

B) Monitor the patient for signs of dehydration and assess bowel movement frequency.

A) Encourage increased fluid intake to manage renal function.

B) Monitor the patient for signs of dehydration and assess bowel movement frequency.

C) Increase the lactulose dosage to further reduce ammonia levels.

D) Educate the patient on the importance of adhering to a low-protein diet.

A patient receiving lactulose therapy for hepatic encephalopathy is experiencing mild abdominal discomfort and increased bowel movements. Given her current condition, including elevated blood pressure and declining renal function, which nursing intervention is most appropriate to address these concerns?

C) Collaborate with the healthcare team to adjust the lactulose regimen and monitor renal function closely.

A) Administer an antiemetic to reduce abdominal discomfort and re-evaluate lactulose dosing.

B) Encourage the patient to increase oral fluid intake to compensate for fluid loss from bowel movements.

C) Collaborate with the healthcare team to adjust the lactulose regimen and monitor renal function closely.

D) Withhold lactulose temporarily to alleviate abdominal discomfort and discuss alternative therapies.

A patient with heart failure is experiencing fluid overload and has been started on continuous renal replacement therapy (CRRT). Her oxygen saturation has improved to 91% after one hour of therapy. Which nursing intervention is most important to implement to ensure the effectiveness of CRRT and improve the patient's respiratory status?

B) Reposition the patient to a high-Fowler's position.

A) Increase the flow rate of the supplemental oxygen.

B) Reposition the patient to a high-Fowler's position.

C) Administer an additional dose of diuretic medication.

D) Restrict the patient's fluid intake to 500 mL per day.

A patient with heart failure and renal impairment has been initiated on continuous renal replacement therapy (CRRT) due to fluid overload and worsening pulmonary congestion. After one hour of therapy, the patient's oxygen saturation improves from 88% to 91%. What is the most appropriate nursing action to ensure the continued effectiveness of CRRT in managing the patient's condition?

B) Monitor the patient's electrolytes and adjust CRRT settings accordingly

A) Increase the rate of CRRT to enhance fluid removal

B) Monitor the patient's electrolytes and adjust CRRT settings accordingly

C) Administer a diuretic to further reduce fluid overload

D) Reduce the patient's fluid intake to prevent further overload

A patient undergoing continuous renal replacement therapy (CRRT) for acute kidney injury is now experiencing altered mental status due to elevated ammonia levels. Which nursing intervention should be prioritized to address the patient's hepatic encephalopathy?

A) Administer lactulose as prescribed to promote ammonia excretion.

B) Provide high-protein diet to support nutritional needs.

C) Decrease fluid intake to prevent volume overload.

D) Discontinue CRRT to alleviate stress on the liver.

A patient undergoing continuous renal replacement therapy (CRRT) for acute renal failure has developed worsening hepatic encephalopathy, indicated by increased confusion and elevated ammonia levels. Which nursing intervention is most appropriate to prioritize in managing this patient's condition?

A) Administer lactulose as prescribed to reduce ammonia levels.

B) Increase protein intake to support liver regeneration.

C) Restrict fluid intake to prevent fluid overload.

D) Monitor for signs of infection to prevent sepsis.

Heart Disease, Kidney Disease, Liver Problem - Nursing Case Study

Pathophysiology

• Heart Disease:

• Primary mechanism: Atherosclerosis leads to plaque buildup in coronary arteries, reducing blood flow to the heart muscle, causing ischemia.

• Secondary mechanism: Hypertension increases the heart's workload, leading to left ventricular hypertrophy and potential heart failure.

• Key complication: Myocardial infarction occurs when a plaque ruptures, causing a blood clot and complete blockage.

• Kidney Disease:

• Primary mechanism: Diabetes causes high blood sugar levels, damaging the glomeruli and leading to diabetic nephropathy.

• Secondary mechanism: Hypertension damages renal blood vessels and decreases kidney function over time.

• Key complication: Progressive loss of kidney function results in end-stage renal disease requiring dialysis.

• Liver Problem:

• Primary mechanism: Chronic alcohol consumption leads to steatosis, inflammation, and fibrosis, progressing to cirrhosis.

• Secondary mechanism: Hepatitis virus infection causes immune-mediated liver cell destruc

Patient Profile

Demographics:

58-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Coronary Artery Disease, Chronic Kidney Disease Stage 3, Non-alcoholic Fatty Liver Disease

• Current medications: Metoprolol, Lisinopril, Metformin, Atorvastatin, Furosemide, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and fatigue

• Key symptoms: Swelling in the lower extremities, decreased urine output, nausea, mild jaundice, occasional chest discomfort

• Vital signs: Blood Pressure 145/95 mmHg, Heart Rate 110 bpm, Respiratory Rate 22 breaths per minute, Temperature 99.1°F, Oxygen Saturation 92% on room air

Section 1

As the healthcare team further assesses the 58-year-old female patient, they note her increasing shortness of breath and swelling in the lower extremities, which suggest worsening heart failure. During the physical examination, crackles are heard upon auscultation of the lungs, indicating pulmonary congestion. Her jugular venous pressure is elevated, suggesting fluid overload. The patient's blood pressure remains elevated at 150/98 mmHg despite her current antihypertensive regimen, and her heart rate persists at 112 bpm, reflecting a compensatory response to decreased cardiac output.

Laboratory results reveal a serum creatinine level of 2.8 mg/dL, indicating a decline in kidney function from her baseline chronic kidney disease stage 3. Her estimated glomerular filtration rate (eGFR) has dropped to 28 mL/min/1.73m². Liver function tests show elevated liver enzymes, with ALT at 65 U/L and AST at 70 U/L, alongside a bilirubin level of 2.5 mg/dL, confirming worsening liver dysfunction. These lab findings correlate with her clinical presentation of mild jaundice and nausea, suggesting that both her renal and hepatic conditions are deteriorating.

In response to these findings, the healthcare team initiates adjustments in her medication regimen, including increasing the dose of furosemide to manage fluid overload and considering the addition of a beta-blocker to better control her heart rate and blood pressure. The patient's oxygen therapy is also initiated to address hypoxia. Given the multifaceted nature of her conditions, a referral to a nephrologist and hepatologist is made to address the complexities of her renal and liver issues. The team discusses the need for close monitoring and possible future interventions, recognizing the potential for further complications such as acute-on-chronic liver failure or progression to end-stage renal disease.

Section 2

As the team closely monitors the patient following the adjustments to her treatment plan, they observe a change in her status. Within 48 hours, the patient's shortness of breath shows some improvement, and her peripheral edema has slightly reduced, indicating a mild positive response to the increased dose of furosemide. However, the patient's heart rate remains elevated at 108 bpm, and her blood pressure, while slightly improved, is still elevated at 145/95 mmHg. Oxygen saturation levels have stabilized at 92% on supplemental oxygen. Despite these modest improvements, the patient reports increased fatigue and a new onset of confusion, raising concerns for potential encephalopathy related to her liver dysfunction.

New laboratory results reveal a further increase in serum creatinine to 3.2 mg/dL, suggesting ongoing renal decline. Liver function tests now show ALT at 75 U/L and AST at 85 U/L, with bilirubin rising to 3.0 mg/dL, indicating continued hepatic deterioration. Additionally, an elevated ammonia level of 90 µmol/L is noted, supporting the suspicion of hepatic encephalopathy. These findings prompt the team to initiate lactulose therapy to lower ammonia levels and address the encephalopathic symptoms.

The healthcare team convenes to reassess the patient’s treatment strategy, recognizing the need to balance aggressive management of her heart failure with careful consideration of her kidney and liver function. Discussions include the potential need for more advanced therapies, such as dialysis or liver support, should her condition continue to deteriorate. The team emphasizes the importance of ongoing interdisciplinary collaboration, including regular consultations with nephrology and hepatology specialists, to tailor interventions that adequately address the complexities of her multiple organ dysfunctions.

Section 3

The next 24 hours bring new challenges as the healthcare team closely monitors the patient's response to the lactulose therapy and the adjustments made to her treatment regimen. Initially, the patient's confusion seems to improve slightly with the administration of lactulose, as she becomes more oriented to time and place. However, her fatigue persists, and she now reports mild abdominal discomfort, likely related to the increased bowel movements induced by the lactulose. The team notes a slight decrease in her heart rate to 102 bpm, but her blood pressure remains elevated at 148/96 mmHg. Her oxygen saturation remains stable at 92% with supplemental oxygen, and the peripheral edema continues to show minimal improvement.

New laboratory results reveal a concerning trend: her serum creatinine has risen further to 3.6 mg/dL, indicating a progression of renal impairment despite ongoing diuretic therapy. Liver function tests show a slight increase in ALT to 80 U/L and AST to 90 U/L, while bilirubin remains elevated at 3.2 mg/dL. Ammonia levels have decreased marginally to 85 µmol/L, suggesting a partial response to the lactulose. These findings highlight the delicate balance needed in managing her heart failure while preventing further renal and hepatic compromise.

The interdisciplinary team convenes once more, recognizing the urgency of addressing her declining renal function. Nephrology suggests initiating continuous renal replacement therapy (CRRT) to manage her fluid overload and alleviate the stress on her kidneys. Meanwhile, hepatology recommends optimizing lactulose dosing while considering the introduction of rifaximin to further reduce ammonia production. The team remains vigilant, aware that any intervention must be cautiously balanced to avoid exacerbating her liver or heart conditions. This integrated approach aims to stabilize her condition while preparing for potential escalation of care should her status continue to decline.

Section 4

As the healthcare team continues to monitor the patient's condition, a new complication arises within the next 12 hours. The patient begins to experience increased difficulty breathing, with respiratory rate climbing to 28 breaths per minute, and she reports a sensation of tightness in her chest. Her oxygen saturation has dropped to 88% despite the supplemental oxygen, prompting a reassessment of her respiratory status. Auscultation reveals diminished breath sounds bilaterally, with crackles heard at the lung bases, suggesting worsening pulmonary congestion. These findings indicate a potential exacerbation of heart failure, likely compounded by fluid overload and renal impairment.

In response to the evolving situation, the team decides to initiate continuous renal replacement therapy (CRRT) as previously discussed. This intervention aims to reduce fluid overload and support renal function by providing gentle and continuous fluid and solute removal. Throughout the initiation of CRRT, the patient's vital signs are closely monitored: her heart rate remains slightly elevated at 104 bpm, blood pressure stabilizes at 140/92 mmHg, and there is a gradual improvement in her oxygen saturation, which rises back to 91% after an hour of therapy. The interdisciplinary team remains cautious, aware of the delicate interplay between her heart, kidney, and liver conditions.

While CRRT begins to address the fluid overload, the team also implements changes to her medication regimen, including the introduction of rifaximin to further manage hepatic encephalopathy and potentially reduce abdominal discomfort associated with lactulose therapy. The patient's response to these interventions will be critical in the coming hours, as the team strives to achieve a balance that supports each organ system without precipitating further decline. As her condition remains precarious, the team prepares for the possibility of more aggressive interventions should her status not stabilize, highlighting the importance of ongoing assessment and clinical reasoning in managing this complex case.

Section 5

As the healthcare team continues to monitor the patient's response to the interventions, particularly the initiation of continuous renal replacement therapy (CRRT), a new complication emerges. Over the next few hours, the patient begins to exhibit signs of altered mental status, becoming increasingly confused and disoriented. Her speech becomes slurred, and she is unable to follow simple commands. Concerned about the potential for worsening hepatic encephalopathy, the team orders a series of diagnostic tests to evaluate her liver function and ascertain the cause of her neurological changes.

The new diagnostic results reveal a significant elevation in the patient's ammonia levels, rising to 145 µmol/L, which correlates with her deteriorating mental status. Her liver function tests show further derangement, with an increase in bilirubin levels to 3.5 mg/dL and an elevation of ALT and AST to 85 U/L and 102 U/L, respectively. These findings, alongside her worsening neurological symptoms, suggest that her liver dysfunction is contributing significantly to the current clinical picture. Meanwhile, her renal function, as indicated by creatinine levels, shows a slight improvement, decreasing to 2.5 mg/dL, a positive response to the CRRT.

In response to the new complications, the team intensifies their management of hepatic encephalopathy. They increase the frequency of lactulose administration to facilitate more effective ammonia clearance, adjust the dose of rifaximin, and ensure that her nutritional support is optimized to prevent further metabolic derangement. Additionally, the team considers the potential need for more aggressive interventions, such as an escalation in liver support measures or preparation for potential transfer to a specialized hepatology center. Throughout this process, the team remains vigilant in monitoring her neurological status, liver function, and overall clinical stability, understanding the critical balance required to manage her complex condition effectively.